APA (7th ed.) Citation

Wilke, A. C., Döbele, C., Zindel, A., Lee, K. S., Rieke, S. A., Ceribelli, M., . . . Oellerich, T. (2022). SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma. Blood, 139(4), . https://doi.org/10.1182/blood.2021012081

Chicago Style (17th ed.) Citation

Wilke, Anne C., et al. "SHMT2 Inhibition Disrupts the TCF3 Transcriptional Survival Program in Burkitt Lymphoma." Blood 139, no. 4 (2022). https://doi.org/10.1182/blood.2021012081.

MLA (9th ed.) Citation

Wilke, Anne C., et al. "SHMT2 Inhibition Disrupts the TCF3 Transcriptional Survival Program in Burkitt Lymphoma." Blood, vol. 139, no. 4, 2022, https://doi.org/10.1182/blood.2021012081.